| Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: the Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) O Arrieta, AF Cardona, C Martín, L Más-López, L Corrales-Rodríguez, ... Journal of Thoracic Oncology 10 (5), 838-843, 2015 | 211 | 2015 |
| EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1. 2-CLICaP) AF Cardona, L Rojas, ZL Zatarain-Barrón, HC Freitas, ST Granados, ... Lung Cancer 125, 265-272, 2018 | 60 | 2018 |
| Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): a randomised … J O'Shaughnessy, S Sousa, J Cruz, L Fallowfield, P Auvinen, C Pulido, ... European Journal of Cancer 152, 223-232, 2021 | 55 | 2021 |
| Methylenetetrahydrofolate reductase polymorphism (677 C> T) predicts long time to progression in metastatic colon cancer treated with 5-fluorouracil and folinic acid O Castillo-Fernández, M Santibáñez, A Bauza, G Calderillo, C Castro, ... Archives of medical research 41 (6), 430-435, 2010 | 37 | 2010 |
| An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP) L Corrales-Rodríguez, O Arrieta, L Mas, R Báez-Saldaña, ... Lung Cancer 113, 30-36, 2017 | 36 | 2017 |
| Cancer immunotherapy-associated hypophysitis F Castillero, O Castillo-Fernández, G Jiménez-Jiménez, J Fallas-Ramírez, ... Future oncology 15 (27), 3159-3169, 2019 | 33 | 2019 |
| Molecular epidemiology of ALK rearrangements in advanced lung adenocarcinoma in Latin America O Arrieta, AF Cardona, G Bramuglia, G Cruz-Rico, L Corrales, C Martín, ... Oncology 96 (4), 207-216, 2019 | 32 | 2019 |
| Chemotherapy in patients with advanced pancreatic cancer: too close to death? M Frigeri, S De Dosso, O Castillo-Fernandez, K Feuerlein, ... Supportive Care in Cancer 21, 157-163, 2013 | 26 | 2013 |
| Real-world treatment patterns, survival, and prediction of CNS progression in ALK-positive non-small-cell lung cancer patients treated with first-line crizotinib in latin … C Martín, AF Cardona, ZL Zatarain-Barrón, A Ruiz-Patiño, O Castillo, ... Oncology 94 (5), 297-305, 2018 | 13 | 2018 |
| HOLA COVID-19 study: evaluating the impact of caring for patients with COVID-19 on cancer care delivery in Latin America C Bernabe-Ramirez, AI Velazquez, C Olazagasti, C Decat Bergerot, ... JCO global oncology 8, e2100251, 2022 | 7 | 2022 |
| HER-2/Neu overepression in gastric cancer R Vergara, I Torrazza, O Castillo Fernandez Journal of Clinical Oncology 27 (15_suppl), e15679-e15679, 2009 | 7 | 2009 |
| Parotid Myoepithelial Carcinoma in a Pediatric Patient with Multiple Recurrences: Case Report OCF Harold Bravo Thompson, Maria Lim Law, Ruth Vergara Vasquez Case Rep Oncol, 2021 | 6 | 2021 |
| Neuroendocrine tumors in Panama: A nationwide database analysis MCRVJDMROCIBETOEAYLHTGPM Peña Molecular and Clinical Oncology 15 (2), 2021 | 5 | 2021 |
| Abstract P1-18-34: Effectiveness of subcutaneous trastuzumab and intravenous pertuzumab as neoadjuvant dual blockade for locally advanced HER2+ breast cancer: Real world … O Castillo-Fernandez, F Castillero, M Lim, C Martin, L Montano, S Benitez, ... Cancer Research 80 (4_Supplement), P1-18-34-P1-18-34, 2020 | 2 | 2020 |
| Budget impact for olaparib maintenance therapy for brca-mutated platinum sensitive recurrent ovarian cancer in panama FGT Toala, J Solorzano, J Baldi, O Castillo-Fernandez Value in Health 21, S22, 2018 | 2 | 2018 |
| EGFR MUTATION AND OUTCOMES IN PATIENTS WITH METASTATIC NSCLC TREATED WITH ERLOTINIB AT INSTITUTO ONCOLOGICO NACIONAL. PANAMA O Castillo-Fernandez, E Arauz, A Cabreja, Y Loo, I Veliz, M Guardia, ... JOURNAL OF THORACIC ONCOLOGY 9 (9), S189-S189, 2014 | 2 | 2014 |
| Prognostic factors for recurrence in elderly patients with cervical carcinoma OO Castillo Fernandez, R Arauz, R Zarak, E Diaz, JC Alcedo, RI Lopez, ... Journal of Clinical Oncology 26 (15_suppl), 16564-16564, 2008 | 2 | 2008 |
| A phase 1, open-label, multicenter study evaluating MK-1084 as monotherapy and in combination with other therapies in patients with KRAS G12C mutant … IA Lugowska, C Rojas, A Stathis, S Weindler, A Pal, E Castanon Alvarez, ... Journal of Clinical Oncology 42 (3_suppl), TPS232-TPS232, 2024 | 1 | 2024 |
| Real-world data of subcutaneous trastuzumab and intravenous pertuzumab as neoadjuvant therapy for localized HER2+ breast cancer in Panama FC Rodriguez, O Castillo-Fernandez, M Lim-Law, CM Palacios, ... Breast Cancer Management 10 (1), BMT, 2021 | 1 | 2021 |
| PCN85 COST-EFFECTIVENESS OF OLAPARIB AS A MAINTENANCE TREATMENT OPTION FOR NEWLY DIAGNOSED BRCA-MUTATED OVARIAN CANCER WHO ARE IN RESPONSE AFTER FIRST-LINE PLATINUM-BASED … O Castillo-Fernandez, S Murtiera, J Solorzano, C Martin, JLA Sosa, ... Value in Health 23, S38, 2020 | 1 | 2020 |
Oscar ArrietaMedical Oncology, Instituto Nacional de Cancerología de MexicoBestätigte E-Mail-Adresse bei unam.mx
